Abstract
Objective
An intracavernous internal carotid artery constriction or occlusion (ICAc/o) has been considered an extremely rare finding in autoimmune hypophysitis (AiHy). This study aimed to analyse predictive factors for the occurrence of ICAc/o in AiHy.
Design
Retrospective analysis of three of our own cases and 16 published cases.
Methods
Among 15 surgically treated patients with AiHy, we identified three cases with ICAc/o via time-of-flight magnetic resonance angiography (TOF MRA) or computed tomography angiography (CTA). In addition, 16 published cases with AiHy and ICAc/o were identified via the literature search. Clinical features, treatment, and outcomes were evaluated.
Results
TOF MRA revealed complete bilateral ICA occlusion (ICAo) in case 1 and incomplete bilateral ICA constriction (ICAc) in case 2. In the third case, left-sided ICAo was confirmed by CTA. None of our three patients with AiHy complicated by ICAc/o suffered brain infarction or neurological deficits. All three cases exhibited a parasellar T2 dark sign and strong dural enhancement. With our three cases included, seven of 19 published cases (36.8%) showed complete bilateral ICAo. Among these, four presented with ischaemic stroke. Eight of 19 patients (42.1%) presented with cranial nerve palsy. While all patients presented with hypopituitarism, only five had arginine vasopressin (AVP) deficiency. Interestingly, 11 patients had a recurrent course of hypophysitis.
Conclusion
ICAc/o caused by AiHy appears to be more frequent than previously reported. Special attention should be paid to the carotid arteries in AiHy because of the potentially deleterious complication of ICAc/o. Cranial nerve palsy, a parasellar T2 dark sign, strong perisellar dural enhancement, and a recurrent course of hypophysitis can be considered warning signs of the occurrence of ICAc/o.
Introduction
Hypophysitis is an umbrella term for various entities involving inflammation of the pituitary gland. It is subclassified into autoimmune hypophysitis (AiHy), with an autoimmune background, and secondary hypophysitis, which is triggered by a wide variety of local and systemic processes (1, 2, 3).
Here, we address incomplete internal carotid artery constriction (ICAc) and complete internal carotid artery occlusion (ICAo) as rare complications of AiHy. Ikeda et al. (4) reported the first case of AiHy with ICAo in 1990. In a review of the literature up to June 2019, Gendreitzig et al. (5) identified seven cases of AiHy with ICAc/o (1, 6, 7, 8, 9, 10, 11). ICAc/o is a potentially lethal complication of hypophysitis, which warrants prompt diagnosis and treatment (9). A particularly high risk of ischaemic stroke exists in cases with ICAo. On the other hand, the early diagnosis of ICAc is paramount to prevent the progressive deterioration of cerebral blood flow and stroke.
This study on AiHy with ICAc/o is based on three of our own patients and 16 previously published cases from the literature. It aimed to identify specific features of AiHy that predispose individuals to ICAc/o and to analyse the outcomes.
Methods
Data collection and inclusion criteria
A total of 2,204 patients with sellar region pathologies underwent transsphenoidal surgery at our department between January 2005 and February 2023. Our surgical series included 15 patients with histopathologically confirmed AiHy. Among these patients, three patients with internal carotid artery constriction or occlusion (ICAc/o) within the cavernous sinus (CS) were identified.
Clinical symptoms, diagnostic findings, treatment, and follow-up data were retrieved from patients’ files.
The study was approved by the ethics committee of the University of Tuebingen (number: 230/2023BO2).
Radiological assessment
Preoperative and postoperative magnetic resonance imaging (MRI) of the sellar region included coronal and sagittal T1-weighted images without and with contrast, coronal T2-weighted images, and axial T2 fluid-attenuated inversion recovery images. The internal carotid arteries (ICAs) and collaterals were assessed using time-of-flight magnetic resonance angiography (TOF MRA) or computed tomography angiography (CTA).
The abbreviation ‘ICAc’ was used if the ICA showed incomplete constriction on imaging studies, and ‘ICAo’ was used if the ICA was completely occluded. ICAc/o addressed both variants.
Endocrinological evaluation
Preoperative, postoperative, and follow-up endocrinological assessments were provided by the referring endocrinologists. In addition, oestradiol, follicle-stimulating hormone, luteinising hormone, free thyroxine, free triiodothyronine, thyroid-stimulating hormone, cortisol, prolactin, growth hormone, and insulin-like growth factor 1 levels were determined the day before surgery and 5 days after surgery during the perioperative hospital stay in our neurosurgical department in a standardised manner.
Transsphenoidal surgery
For transsphenoidal biopsy, all patients were placed under general anaesthesia in the supine position, with the head reclined at 10°. Transsphenoidal surgery was performed under the operating microscope. A direct prenasal approach with the septum-pushover technique was used.
Histopathological analysis
The histopathological analysis included evaluation of CD3+ T cells, CD20+ B cells, CD138+ plasma cells, IgG4+ plasma cells, reticulin, and the pituitary gland’s tissue structure.
Literature research
A PubMed search was performed to identify publications in English or German up to December 2024. The search terms ‘hypophysitis’ combined with ‘carotid artery’ and ‘hypophysitis’ combined with ‘CS’ were used. Full-text articles were reviewed to identify published cases of AiHy and ICAc/o. Citation searches of the reviewed articles were performed to identify additional cases.
Results
Case 1
In 2008, a 35-year-old female patient presented with weight loss and vomiting. She had a history of schizoaffective disorder. An endocrinological evaluation revealed panhypopituitarism, and replacement therapy with hydrocortisone and L-thyroxine was commenced. She was also taking an oral contraceptive. No evidence of arginine vasopressin (AVP) deficiency was found throughout her case history. MRI showed an intrasellar lesion with a slight suprasellar extension and clear thickening of the pituitary stalk, as well as a parasellar T2 dark sign and dural enhancement suggestive of AiHy (Table 1). The clinical, endocrinological, and radiological findings remained unchanged on regular follow-up examinations until 2015.
Radiological findings in three own cases with ICAc/o.
Radiological findings | Case 1 | Case 2 | Case 3 |
---|---|---|---|
Internal carotid artery (ICA) | Bilateral ICA occlusion | Bilateral ICA constriction | Left-sided ICA occlusion |
Parasellar T2 dark sign | Yes | Yes | Yes |
Pituitary stalk thickening | Yes | No | Yes |
Pituitary stalk loss of top bottom tapering | Yes | No | Yes |
Strong contrast enhancement | Yes | Yes | No |
Necrosis | No | No | Yes |
Loss of bright spot | Yes | Yes | Yes |
Compression of optic chiasm | Yes | Yes | No |
Perisellar dural enhancement | Yes | Yes | Yes |
Sphenoid sinus mucosa thickening | Yes | Yes | Yes |
In 2015, the patient complained of blurry vision and weight gain with food cravings (Table 2). An examination of the cerebrospinal fluid (CSF) revealed slight lymphocytic pleocytosis. The serum and CSF were negative for soluble interleukin-2 receptor and angiotensin-converting enzyme. MRI revealed a significant increase in the pituitary lesion (Fig. 1). TOF MRA and carotid Doppler sonography showed bilateral ICAo (Fig. 1, Table 2). The anterior circulation was supplied by collaterals from the vertebrobasilar circulation via a large left and small right posterior communicating artery (Fig. 1). No signs of brain infarction were detected. Under the presumptive diagnosis of AiHy, treatment with methylprednisolone was started, with prompt improvement of the visual disturbance (Table 3). However, treatment had to be discontinued after 10 days because of the exacerbation of her psychosis.
Clinical presentation in the 16 literature cases and three own cases with AiHy and ICAc/o.
Authors/year | † Age/gender | Symptoms | ‡ Duration (months) | Optomotor nerve palsy | Hypopituitarism | AVP deficiency | ICAc/o | Infarction (MRI) | Neurological deficit | |
---|---|---|---|---|---|---|---|---|---|---|
1 | Ikeda et al. (1990) (4) | 45 f | Blurred vision, headache, abnormal thirstiness | 36 | No | Panhypopit | ‘Abnormal thirstiness’ | Bilat ICAo | None | None |
2 | Supler et al. (1992) (12) | 56 m | Retroorbital headache | 5 | Right abducens nerve palsy | Panhypopit | No | Right ICAo | None | None |
3 | Leung et al. (2004) (8) | 57 m | Headache, decreased libido, lethargy | 18 | No | Hypothyroidism, hypogonadism | No | Bilat ICAo | Bilat ischaemic infarction | Severe impairment, prolonged rehabilitation |
4 | Melgar et al. (2006) (9) | 38 f | Initial: diplopia, headache; at the time of ICAo diagnosis: headache | 22 | Right abducens nerve palsy | Slightly low cortisol, otherwise normal | No | Bilat ICAo | Bilat fronto-parietal ischaemic infarction | Perioral tingling, slurred speech, weakness and hypoesthesia in lower extremities |
5 | Nakata et al. (2010) (13) ‘case 1’ | 38 f | Headache, vomiting, polyuria, polydipsia | 11 | No | Hypogonadism | Yes | Left ICAc | None | None |
6 | Nakata et al. (2010) (13) ‘case 2’ | 53 m | Decreased libido | NA | No | Hypogonadism | No | Left ICAc | None | None |
7 | Nakata et al. (2010) (13) ‘case 4’ | 36 m | Decreased libido, polyuria, polydipsia | 8 | No | Hypogonadism | Yes | Right ICAc | None | None |
8 | Peruzzotti-Jametti et al. (2012) (10) | 55 f | Headache, nausea | 10 | No | Not mentioned | No | Bilat ICAo | Left fronto-parietal ischaemic infarction | Slurred speech, right hemiparesis |
9 | Zoeller et al. (2012) (11) | 41 m | Initial: left eye pain, visual loss; at the time of ICAc diagnosis: right eye pain, visual loss, headache, dizziness, fatigue | >6 | No | Hypocortisolism (iatrogenic), hypogonadism | No | Right ICAc | None | None |
10 | Kanoke et al. (2013) (6) | 53 f | Dull headache, retroorbital heavy feeling | NM | No | Hypothyroidism, hypogonadism | No | Right ICAc | None | None |
11 | Katsiveli et al. (2016) (7) | 48 f | Headache, muscle weakness | ‘Previous months’ | No | Panhypopit | No | Bilat ICAo | Small fronto-parietal ischaemic infarction | Slurred speech, right-sided hemiparesis |
12 | Pekic et al. (2018) (1) | 42 f | Headache, diplopia, amenorrhoea, dizziness | 24 | Right abducens nerve palsy | Hypocortisolism | No | Subtotal right ICAc, left ICAo | NM | None |
13 | *Lin et al. (2020) (14) | 50 f | Initial: headache, diplopia; at the time of ICAo diagnosis: again headache, diplopia | 24 | Minor bilateral abducens nerve palsy | Hypogonadism | No | Bilat ICAo | None | None |
14 | Gendreitzig et al. (2020) (5) | 29 f | Headache, nausea, vomiting, fatigue, adrenal crisis | 137 | ‘Diplopia’ | Panhypopit | Yes | Bilat ICAc | None | None |
15 | Rojas et al. (2022) (16) | 54 f | Intense headache | 52 | No | Hypothyroidism hypogonadism | Yes | Left ICAo | None | None |
16 | Watanabe et al. (2023) (15) | 75 f | Initial: nausea, vomiting; at the time of ICAc diagnosis: right ocular pain | 10 | Right oculomotor nerve palsy | Panhypopit | Yes | Severe right ICAc | NM | None |
17 | Own case 1 | 35 f | Initial: weight loss, vomiting; at the time of ICAo diagnosis: blurred vision, weight gain | 84 | Left abducens nerve palsy | Panhypopit | No | Bilat ICAo | None | None |
18 | Own case 2 | 48 f | Headache, double vision, nausea, adynamia | 0.5 | Right oculomotor nerve palsy & abducens nerve palsy | Hypothyroidism hypocortisolism | No | Bilateral ICAc | None | None |
19 | Own case 3 | 31 f | Tiredness, muscle pain, amenorrhoea, headache, weight loss | 18 | No | Panhypopit | No | Left ICAo | None | None |
Previously reported by Waldie et al. (2019) (17).
Age at initial symptom onset.
Duration from initial symptom onset to diagnosis of ICAc/o.
Abbreviations: Bilat, bilateral; ICAo, internal carotid artery occlusion; ICAc, internal carotid artery constriction; NM, not mentioned; Panhypopit, panhypopituitarism.
Case 1. (A) Sagittal T1-weighted MRI post-contrast at the time of bilateral ICAo diagnosis in 2015 shows intrasellar hypophysitis with suprasellar extension. Strong dural enhancement is found (arrow). (B) Coronal T1-weighted MRI post-contrast shows bilateral CS infiltration and ICA occlusion (arrows). Non-tapering of the pituitary stalk is found (asterisk). (C) T2-weighted MRI demonstrates parasellar T2 dark sign (arrow). (D) 3D TOF MRA confirms bilateral ICA occlusion (asterisk for right side) and supply of the anterior circulation mainly via a large posterior communicating artery on the left side (arrow). Following treatment with GC and short-term azathioprine, sagittal MRI (Fig. 1E) and TOF MRA (Fig. 1F) from October 2019 demonstrated size reduction of hypophysitis but persistent bilateral occlusion of the ICA. Postoperative sagittal (G) and coronal (H) T1-weighted MRI post-contrast from June 2021 demonstrate a reduced size of the pituitary lesion.
Citation: Endocrine Connections 14, 6; 10.1530/EC-25-0120
Treatment in the 16 literature cases and three own cases with AiHy and ICAc/o.
Authors/year | Age/gender | Transsphenoidal surgery | Histopathological diagnosis | Recurrent course of hypophysitis | Treatment for hypophysitis and ICAc/o | Specific treatment for ICAc/o | |
---|---|---|---|---|---|---|---|
1 | Ikeda et al. (1990) (4) | 45 f | Partial removal | Lymphocytic hypophysitis | No | NM (no follow-up) | None |
2 | Supler et al. (1992) (12) | 56 m | Biopsy | Lymphocytic hypophysitis | No | None | None |
3 | Leung et al. (2004) (8) | 57 m | ‘Surgery’ | Granulomatous hypophysitis | No | NM | None |
4 | Melgar et al. (2006) (9) | 38 f | Partial resection | Lymphocytic hypophysitis | Yes | Prednisone pulse (twice) | Bilateral superficial temporal artery-distal middle cerebral artery bypass surgery |
5 | Nakata et al. (2010) (13) ‘case 1’ | 38 f | Biopsy | Lymphocytic hypophysitis | NA | NA | NA |
6 | Nakata et al. (2010) (13) ‘case 2’ | 53 m | Biopsy | Lymphocytic hypophysitis | No | None | None |
7 | Nakata et al. (2010) (13) ‘case 4’ | 36 m | No surgery | None (clinical diagnosis of lymphocytic hypophysitis) | NA | NA | NA |
8 | Peruzzotti-Jametti et al. (2012) (10) | 55 f | Biopsy | Lymphocytic hypophysitis | Yes | ‘Steroid therapy’ | None |
9 | Zoeller et al. (2012) (11) | 41 m | Biopsy | Lymphocytic hypophysitis | Yes | ‘High dose steroids’ (twice), prednisone pulse (twice), ‘another course of steroids’ | Acetylsalicylic acid |
10 | Kanoke et al. (2013) (6) | 53 f | Biopsy | IgG4-related hypophysitis | No | High-dose hydrocortisone pulse | None |
11 | Katsiveli et al. (2016) (7) | 48 f | No surgery | None (clinical diagnosis of lymphocytic hypophysitis) | Yes | Methylprednisolone, methylprednisolone escalated, azathioprine | Anticoagulant treatment |
12 | Pekic et al. (2018) (1) | 42 f | Biopsy & decompression | Lymphocytic hypophysitis | Yes | Prednisone pulse, methylprednisolone (switched to prednisone), azathioprine, gamma knife radiosurgery | None |
13 | *Lin et al. (2020) (14) | 50 f | Biopsy | Lymphocyctic hypophysitis | Yes | Methylprednisolone (3 pulses), azathioprine, rituximab (twice), mycophenolate mofetil | None |
14 | Gendreitzig et al. (2020) (5) | 29 f | Resection (twice) | Granulomatous hypophysitis | Yes | Prednisolone pulse, azathioprine, rituximab | Acetylsalicylic acid |
15 | Rojas et al. (2022) (16) | 54 f | Biopsy | IgG4-related hypophysitis | Yes | Methylprednisolone (twice), cyclophosphamide, rituximab | None |
16 | Watanabe et al. (2023) (15) | 75 f | Biopsy | Lymphocytic hypophysitis | Yes | Methylprednisolone (three times), azathioprine | Acetylsalicylic acid |
17 | Own case 1 | 35 f | Biopsy | Lymphocytic hypophysitis | Yes | Methylprednisolone (three times), azathioprine | None |
18 | Own case 2 | 48 f | Biopsy | Lymphocytic hypophysitis | Yes | Prednisolone | None |
19 | Own case 3 | 31 f | Biopsy | Lymphocytic hypophysitis | No | Prednisolone pulse | None |
Previously reported by Waldie et al. (2019) (17).
In October 2019, the patient experienced another episode, with a severe decline in vision in her left eye and a headache that resolved with 500 mg methylprednisolone over 3 days, which precipitated another psychotic episode. She also received short-term treatment with azathioprine, which had to be terminated because of deteriorated haematopoiesis (Table 3). Following medical treatment, MRI demonstrated reduction of lesion size, and TOF MRA showed persistence of bilateral ICA occlusion (Fig. 1).
In October 2020, the patient presented to our neurosurgical department due to newly developed double vision. Left-sided incomplete abducens nerve palsy was found. MRI showed a slight increase in the pituitary lesion. Because of the severe and recurrent course of her condition, we decided to perform a biopsy for a definite diagnosis (Table 3). During transsphenoidal surgery, greyish and firm intrasellar tissue and atrophic anterior pituitary tissue were found. Histopathological evaluation of the biopsy showed infiltration of the anterior pituitary gland with CD3+ T-lymphocytes and, to a lesser extent, with CD20+ B-lymphocytes, confirming the diagnosis of LyHy. There were only single CD138+ plasma cells and no IgG4+ plasma cells (Fig. 2, Table 3).
In all three cases, the pituitary gland showed a lymphocytic infiltration with CD3+ T-lymphocytes and variable numbers of CD138+ plasma cells. IgG4+ plasma cells were absent or only rarely found, thus not indicating IgG4-related hypophysitis.
Citation: Endocrine Connections 14, 6; 10.1530/EC-25-0120
In the postoperative course, the abducens nerve palsy spontaneously regressed (Table 4). Postoperative MRI showed a clear decrease of the space-occupying lesion (Fig. 1). In November 2024, she suffered a recurrence with visual decline, which regressed after 4 days of high-dose prednisolone treatment. Currently, she declines non-steroidal immunosuppressive treatment for fear of side effects.
Final outcome in the 16 literature cases and three own cases with AiHy and ICAc/o.
Authors/year | Age/gender | ICAc/o | Neurological deficit | Optomotor nerve palsy | Hypopituitarism | Pituitary lesion size | General outcome | † Follow-up | |
---|---|---|---|---|---|---|---|---|---|
1 | Ikeda et al. (1990) (4) | 45 f | NM (no follow-up) | NA | NA | NA | NA | NA | 0 months |
2 | Supler et al. (1992) (12) | 56 m | Unchanged | None | Completely resolved | Panhypopit | Unchanged | Headache not mentioned | 6 months |
3 | Leung et al. (2004) (8) | 57 m | NM | Relative independence, unable to return to work | NM | New hypocortisolism | NM | No headache | 107 months |
4 | Melgar et al. (2006) (9) | 38 f | Patent right-sided anastomosis, good cerebrovascular reserve | Symptoms resolved | Completely resolved | Unchanged | Unchanged mass | Returned to her previous occupation | 16 months |
5 | Nakata et al. (2010) (13) ‘case 1’ | 38 f | NA | NM | NM | NM | NM | NM | 11 months |
6 | Nakata et al. (2010) (13) ‘case 2’ | 53 m | Unchanged | NM | NM | NM | NM | NM | 8 months |
7 | Nakata et al. (2010) (13) ‘case 4’ | 36 m | NA | NA | NA | NA | NA | NA | 18 months |
8 | Peruzzotti-Jametti et al. (2012) (10) | 55 f | Unchanged | NM | None | NM | NM | NM | NM |
9 | Zoeller et al. (2012) (11) | 41 m | Not mentioned | None | None | Hypocortisolism, hypogonadism | Regression | Vision improved, constitutional symptoms significantly improved | 3 months |
10 | Kanoke et al. (2013) (6) | 53 f | Regressed | None | None | NM (‘taking 0.5 mg dexamethasone’) | NM | Good condition, symptom free | 6 months |
11 | Katsiveli et al. (2016) (7) | 48 f | Unchanged | Probably none (but not fully clear) | None | Restored | Reduction of pituitary mass | No clinical evidence of disease | 12 months |
12 | Pekic et al. (2018) (1) | 42 f | Not mentioned | None | None | Panhypopit | Regressed | Symptom free | 48 months |
13 | *Lin et al. (2020) (14) | 50 f | Unchanged | None | None | Hypogonadism | Unchanged | Remains well, headaches improved, no eye problems | 30 months |
14 | Gendreitzig et al. (2020) (5) | 29 f | Regressed | None | None | Unchanged | Unchanged | Symptom free, working fulltime | 42 months |
15 | Rojas et al. (2022) (16) | 54 f | Unchanged | None | None | NM | Still pituitary mass | Asymptomatic | 29 months |
16 | Watanabe et al. (2023) (15) | 75 f | Persistent | None | Improved | NM | Decreased | NM | Duration NM |
17 | Own case 1 | 35 f | Persistent | None | Regressed | Unchanged | Decreased | Clinically stable | 115 months |
18 | Own case 2 | 48 f | Regressed | None | Regressed | Hypocortisolism recovered | Minimal regression | Feeling well | 55 months |
19 | Own case 3 | 31 f | Persistent | None | None | Unchanged | Regressed | Feeling better | 23 months |
Previously reported by Waldie et al. (2019) (17).
After diagnosis of ICAc/o.
Abbreviations: NA, not available; NM, not mentioned; Panhypopit, panhypopituitarism.
Case 2
In May 2020, a 48-year-old female patient presented to our neurosurgical department with a 2-week history of severe headache and neck pain followed by double vision and slight nausea a few days later (Table 2). She also reported increasing adynamia. Her menstrual cycle was normal. An endocrinological evaluation showed mild secondary hypothyroidism. Prolactin was mildly elevated. There was no evidence of adrenal insufficiency, growth hormone deficiency, or hypogonadism. Surprisingly, serum cortisol became subnormal 3 days later, and replacement therapy with hydrocortisone was commenced (Table 2). An ophthalmological examination revealed a right-sided incomplete oculomotor nerve palsy and abducens nerve palsy (Table 2). The visual fields were normal. MRI showed a symmetrical intrasellar and suprasellar lesion with homogeneous contrast uptake and a slight elevation of the optic chiasm (Fig. 3). A parasellar T2 dark sign and broadening of the CS were found. MRI and TOF MRA revealed bilateral intracavernous narrowing of the internal carotid artery that was more pronounced on the left side (Fig. 3). Lumbar puncture revealed a count of 12 lymphocytes/μL and was otherwise normal. The suspected diagnosis of LyHy was confirmed by transsphenoidal surgery, which was performed in June 2020 (Fig. 2, Table 3). Immunoglobulin G4 (IgG4)-positive plasma cells were rarely found, excluding a diagnosis of IgG4-related hypophysitis. Postoperatively, the ocular nerve palsies rapidly regressed (Table 4). Therefore, immunosuppressive treatment was withheld. On postoperative TOF MRA, complete regression of ICA narrowing was found (Fig. 3). FDG-PET/MRI showed no evidence of systemic IgG4-related disease. Two months after surgery, a short Synacthen test showed a normalised adrenal axis, and hydrocortisone was discontinued. In August 2024, the patient suffered recurrence of double vision that regressed after treatment with 1,000 mg prednisolone over 5 days. At present, she is feeling well and has a normal ophthalmological status (Table 4).
Case 2. (A) Sagittal T1-weighted MRI post-contrast at initial presentation shows intrasellar hypophysitis with suprasellar extension. Strong dural enhancement (arrow) and swelling of the sphenoid sinus mucosa are found. (B) Coronal T1-weighted MRI post-contrast shows bilateral CS infiltration with bulging of the CS towards the temporal lobe (black arrow) and narrowing of the left ICA (white arrow). (C) 3D TOF MRA confirms bilateral constriction of the ICA within the CS (arrows). (D) Follow-up 3D TOF MRA shows regression of ICA constriction with normal ICA diameters.
Citation: Endocrine Connections 14, 6; 10.1530/EC-25-0120
Case 3
A 31-year-old female patient presented to an external endocrinological department in January 2023 with tiredness, muscle pain, secondary amenorrhoea, and headache (Table 2). She reported long-standing arterial hypertension and had lost 7 kg of body weight in the past 18 months. An endocrinological evaluation revealed panhypopituitarism, with a serum cortisol level as low as 0.8 μg/dL (Table 2). Fluid intake and output were within normal limits. The patient was started on 30 mg hydrocortisone and 50 μg L-thyroxine per day. Her neurological status was normal. MRI showed an intrasellar and slightly suprasellar lesion with a central cystic or necrotic appearance, enlargement of the pituitary stalk, and a parasellar T2 dark sign (Fig. 4). A presumptive diagnosis of LyHy was made. MRI demonstrated complete occlusion of the left ICA within the CS, which was confirmed by CTA (Fig. 4). No evidence of cerebral ischaemia was found on MRI. Because of the serious finding of ICAo, we recommended a transsphenoidal biopsy to clearly confirm the diagnosis. Thus, the patient was referred to our neurosurgical department and a biopsy was performed via a transsphenoidal approach in January 2023 (Table 3). The histopathological examination confirmed the diagnosis of LyHy with both B-lymphocytes and T-lymphocytes, with the latter prevailing. Focally, several CD138+ plasma cells were noted, among them only singular IgG4+ plasma cells (Fig. 2, Table 3).
Case 3. (A) Sagittal T1-weighted MRI post-contrast at initial presentation shows an intrasellar space-occupying lesion. Strong dural enhancement is found (arrow). (B) Coronal T1-weighted MRI post-contrast shows occlusion of the left ICA (white arrow). (C) CT angiography confirms complete occlusion of the left ICA in the cavernous segment (asterisk) and a perfused right ICA with normal calibre (arrow). (D) T2-weighted MRI demonstrates parasellar T2 dark sign (arrow). (E) Sagittal T1-weighted MRI post-contrast shows reduced size of the lesion following surgery and GC therapy. (F) Coronal T1-weighted MRI post-contrast shows persistent occlusion of the left internal carotid artery following surgery and GC therapy (white arrow) and a regular flow signal in the normal-sized right internal carotid artery (black asterisk).
Citation: Endocrine Connections 14, 6; 10.1530/EC-25-0120
Having confirmed the diagnosis, prednisolone pulse therapy was commenced in February 2023 with a starting dose of 50 mg daily (Table 3). In November 2023, Doppler sonography and CTA showed persistent ICAo and normal perfusion of the right ICA, as well as normal cerebral perfusion. Under prednisolone treatment, the patient’s general well-being was much improved. As rapid tapering of prednisolone was not tolerated, the dose was slowly reduced and reached a replacement dose in October 2024. Postoperative endocrinological follow-up examinations showed unchanged panhypopituitarism. MRI from December 2024 showed regression of the pituitary lesion, but the persistence of left-sided ICAo (Table 4; Fig. 4).
Review of the literature
Clinical presentation
In the literature, 16 cases of AiHy with ICAc or ICAo were reported between 1990 and 2024 (1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17). The present study adds three cases (Tables 2, 3, 4). The average age at initial presentation with AiHy was 46 years, and the average age at the time of ICAc/o diagnosis was 48 years. Interestingly, an association with pregnancy was not found in any of the cases.
Of 19 patients, eight patients presented with cranial nerve (CN) palsy as a clinical sign of CS involvement (Table 2). The CNs III and VI were affected, with a predominance of CN IV (abducens nerve). Four patients (cases 1, 2, 9, 17) presented with chiasmal syndrome.
All patients suffered from some degree of hypopituitarism, with seven suffering from panhypopituitarism. Interestingly, only five patients suffered clear AVP deficiency (Table 2).
Bilateral ICAo was observed in seven cases (36.8%); see Table 2. Four of them suffered ischaemic stroke with neurological deficits (Table 2). Of note, three patients with bilateral ICAo remained free of cerebral infarction and were neurologically intact. None of the patients with incomplete ICAc or unilateral pathology suffered infarction or neurological deficits.
Eleven of 19 patients (57.9%) had a recurrent course of hypophysitis (Table 3). In eight patients, ICAc/o was detected during a recurrent episode of hypophysitis.
Treatment
The subtype of hypophysitis was confirmed in 17 cases by transsphenoidal biopsy. Biopsy was undertaken in 12 patients at the time when ICAc/o was detected, in three patients at an earlier stage (cases 4, 14, 16), and in one patient at a later stage (case 17). The time of surgery was not available for one patient. Among the 17 cases with biopsy, 13 cases suffered from LyHy, two had GrHy, and two had IgG4-related hypophysitis (Table 3). In our own cases, the histopathological findings were not different from typical findings in AiLy without ICAc/o. In particular, no evidence of severe destructive inflammation indicating aggressiveness was found (Fig. 2).
Thirteen of 15 patients with sufficient treatment information were treated with glucocorticoids (GC), some with several GC pulses (Table 3). From 2016 onward, seven patients were treated with non-steroidal immunosuppressive medication (Table 3). In one patient with a difficult clinical course, stereotactic radiosurgery with Gamma Knife was successfully performed.
In six cases, clear evidence exists that ICAc/o influenced the management (bypass surgery in one case and more aggressive treatment with GC and/or non-steroidal immunosuppression in five cases). In five additional cases, ICAc/o has likely influenced the management with more extensive immunosuppressive treatment. In two of these cases, incomplete ICAc was reversible under intensified treatment.
In one patient, reduced cerebral perfusion was treated with a bilateral cerebral bypass surgery (Table 3). Anticoagulant or antiplatelet treatment was reported in four patients.
Outcome
The mean follow-up period after diagnosis of ICAc/o was 32.2 months (range 0–115 months; median 12 months).
ICAo was irreversible in all affected patients. In contrast, incomplete ICAc regressed in three patients (Table 4). One out of four patients with cerebral stroke had an adverse neurological outcome. The outcome of CN palsies was favourable (Table 4). A decrease in the pituitary lesion during follow-up was reported in seven patients, unchanged size in five patients, and no information on final lesion size in seven patients. The overall outcome was reported to be favourable in 12 patients and not reported in six patients, while one patient remained disabled following an ischaemic stroke.
Posterior pituitary function remained unchanged during follow-up in all cases (Table 4). Anterior pituitary function was restored in only one patient (case 11).
Discussion
ICA occlusion or constriction is a serious complication of AiHy. It can cause disabling neurological deficits or even result in fatal outcomes. We report three of our cases of AiHy with ICAc/o and 16 previous cases identified by the literature search. Our study aimed to characterise cases of ICAc/o and to identify predictive factors and warning signs that allow early diagnosis.
In pathologies with CS involvement, the serious sequelae of arterial constriction and occlusion may occur (4, 18, 19, 20). ICAc/o is mainly found in benign neoplasms, AiHy, and fungal or bacterial infections (5, 21, 22, 23).
In an MRI study, Molitch et al. (24) analysed ICA compression in 83 patients with pathologies encasing the ICA. Only 1/58 (1.7%) pituitary adenomas but 7/25 (28%) of non-pituitary adenoma lesions showed ICA compression.
Katsiveli et al. (7) pointed out that, as of 2016, only two cases of bilateral ICAo along with aggressive forms of LyHy had been reported. They concluded that bilateral ICAo associated with AiHy is an exceptionally rare clinical entity. The number of cases has rapidly increased since then, with 19 cases reported here. Gendreizig et al. (5) analysed the entities causing ICAc/o in 36 published cases and found that 19% of ICAc/o was caused by hypophysitis, making it the second most common cause after pituitary adenomas. They concluded that hypophysitis is not as rare a cause of ICAc/o as previously considered. It was likely underreported previously because of less sophisticated detection techniques.
Given a reported yearly incidence of AiHy of only one person per 9 million (25), the relative prevalence of ICAc/o among patients with AiHy is much higher than in pituitary adenomas.
ICAc/o is a potentially life-threatening sequela of CS invasion and is associated with a high rate of neurological deficits secondary to cerebral stroke (5, 9). It is of note that none of the reported patients with ICAo secondary to hypophysitis had a fatal outcome, but fatalities have been described in other pathologies causing ICAo (5, 21). Therefore, ICAo must be regarded as a potentially life-threatening complication of hypophysitis. Early diagnosis is paramount and can be life-saving. Our review of the literature showed that four of seven patients with AiHy and bilateral ICAo suffered a cerebral stroke, while three patients had neither radiological nor clinical evidence of cerebral infarction. We and others postulate that ICAc can slowly progress in hypophysitis, allowing development of arterial collaterals, and is therefore compensated without leading to cerebral infarction in some cases (4, 5, 7, 8, 9). This theory is supported by the finding that most reported cases had a prolonged course of hypophysitis, and ICAo was not found at the initial diagnosis but at the stage of recurrence. In the four patients with symptomatic ICAo, neurological signs suggestive of stroke also developed with delay. The time span from initial symptoms of hypophysitis to development of neurological symptoms was 18, 22, 10 months, and greater than 9 months, respectively. This finding supports the hypothesis that chronic or recurrent inflammation rather than acute inflammation caused ICAc/o.
The pathophysiology of ICAc/o is not fully understood. It obviously occurs because of spread of the inflammatory process to the CS that hosts the carotid artery (7). However, it is unclear whether ICAc/o is purely caused by compression of the ICA. Infiltration and consecutive thickening of the ICA wall is another factor that likely contributes to ICAc/o (6, 16).
CS infiltration by AiHy may cause diplopia, eye pain, ptosis, facial numbness, or trigeminal neuralgia. A considerable number of hypophysitis patients with ICAc/o suffered from optomotor deficits (Table 2). This is a plausible finding, as the CS hosts CNs III, IV, and VI, which regulate eye movement. CN VI (abducens nerve), with its course through the CS, was predominantly affected. Given these findings, optomotor nerve palsy in AiHy should alert clinicians to the need for a close look at the CS and the ICA. In contrast to the cases with ICAc/o, optomotor nerve palsies were found in fewer than 10% of the patients with AiHy without ICAc/o (26). If the ICA is conspicuous on MRI, further examination – such as via TOF MRA, CTA, and digital subtraction angiography – is indicated. TOF MRA is our preferred imaging technique if ICAc/o is suspected. It should also be performed in the follow-up of patients with confirmed ICAc.
Another conspicuous finding of hypophysitis with ICAc/o is that only one in four of the patients suffered from obvious AVP deficiency, which contrasts with the value of 47% in a recent meta-analysis of all published cases with LyHy (27). This observation suggests that the cases with ICA narrowing mainly represent the lymphocytic adenohypophysitis variant.
AiHy typically presents as a symmetrical pituitary mass with homogeneous and strong contrast enhancement (3, 28). The most characteristic radiological sign of hypophysitis is the thickening of the stalk, reported in up to 86% of the cases (26, 28). Only a minority of 10% exhibit CS involvement (27).
Nakata et al. (13) described the parasellar T2 dark sign as a typical finding in AiHy with CS involvement and found a 100% specificity in differentiating AiHy from pituitary adenomas. The T2 dark sign is found around the CS and pituitary gland and within the CS. Most likely, it reflects fibrotic changes and thickening of dural structures caused by the inflammatory process of hypophysitis (13). We also found a parasellar T2 dark sign in all three of our cases. Therefore, it is important to pay attention to the parasellar T2 dark sign in every case with AiHy to identify CS infiltration with the potential risk of ICAc/o. The T2 dark sign was also shown on the MRI of some published cases. Of note, a pronounced perisellar dural enhancement (‘dural tail’) was found in our three cases and other published cases with ICAc/o (6, 7). It can be considered a further sign of spread outside the pituitary fossa boundaries and should be looked for in AiHy (6, 28).
High-dose glucocorticoid (HD-GC) administration is considered the mainstay of AiHy treatment and is associated with a high initial response rate (2, 29). However, it is associated with a higher recurrence rate when compared to observation (27, 29). Non-steroidal immunosuppressive drugs, such as azathioprine or rituximab, are also proven to be effective and are usually used if treatment with GCs fails (1, 5, 16).
In a German cohort study on AiHy without ICAc/o, 30% of patients were initially treated with HC-GCs and 1% with non-steroidal immunosuppressive medication (29). Forty percent did not require such treatment and were solely kept under observation. Similar results were found in an observational study of 113 patients with AiHy, with initial observation in 52.2% of patients and HC-GC therapy in 18.6% (30).
In contrast, among the reported patients with ICAc/o, the need for immunosuppressive medication was much higher, with HD-GCs in 92.9% and non-steroidal immunosuppressive medication in 38.8%. This underlines that hypophysitis complicated by ICAo/n is mostly found in aggressive and recurrent clinical forms of hypophysitis, necessitating multiple medical treatments.
Based on the findings in our review, we recommend resolute treatment of hypophysitis in the presence of the identified predictors for ICAo/c (i.e. CN palsy, parasellar T2 dark sign, strong perisellar dural enhancement, and recurrent course of hypophysitis) not only for patients who already present with incomplete ICAc but also for patients without radiological signs of ICA abnormalities. Similarly, Peruzzotti-Jametti et al. (10) have pointed out, ‘In our case, in fact, early testing could have prevented the bilateral occlusion of the ICAs, stroke, and subsequent disability’. However, the evidence from our literature review suggests that resolute treatment (with GC and/or non-steroidal immunosuppression) is not absolutely necessary if bilateral ICAo has already occurred.
In all but two cases, the subtype of hypophysitis was confirmed by transsphenoidal biopsy (Table 3). In contrast, surgery has been used in only 25–30% of the cases of AiHy without ICAc/o (29, 30). We hypothesise that the aggressive clinical course of hypophysitis and/or the impending threat because of ICAc/o were the reasons to confirm the diagnosis by biopsy in the reported cases. The threat of ICAc/o was also an indication for surgery in our three patients.
In cases with hypophysitis and ICAc/o, treatment to improve cerebrovascular perfusion is an additional important issue. In the case of insufficient collaterals with symptoms due to hypoperfusion, bypass surgery should be discussed. In the literature, reperfusion of the ICA never occurred once complete occlusion of the ICA was detected. In contrast, incomplete ICAc resolved in three of nine cases. One of the three patients with regression of ICAc had received high-dose hydrocortisone pulse therapy (6), one was treated with prednisolone, azathioprine, and rituximab (5), and in our case 2, ICA narrowing resolved spontaneously.
Katsilveli et al. (7) concluded that prompt identification of artery occlusion in hypophysitis is critical and should lead to the optimisation of medical management, thereby preventing clinical deterioration with stroke or other grave consequences.
The literature shows that hypophysitis with ICAc/o is a threatening disorder that frequently requires more than the standard treatment for hypophysitis. We strongly recommend a biopsy of the lesion, which is easily performed via a transsphenoidal approach, if there is any doubt about the precise diagnosis. This will allow the targeted treatment of the underlying disorder. An impending ICAo necessitates active treatment instead of watchful waiting.
Conclusion
ICAc/o in AiHy is apparently more frequent than previously reported. We add three more cases to the literature on this subject. ICAc/o is caused by a spread of the inflammatory process to the CS, followed by ICA compression and probable thickening of the arterial wall. The recurrence of hypophysitis, optomotor nerve palsy, and the parasellar T2 dark sign should alert the treating physicians to the possible involvement of the ICA. Special attention to the carotid arteries is warranted because ICAo is a severe sequela of hypophysitis associated with a considerable risk of adverse neurological outcomes.
Declaration of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the work reported.
Funding
This work did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.
Ethics approval
The study was approved by the ethics committee of the University of Tuebingen (number: 230/2023BO2).
Acknowledgement
We acknowledge support from the Open Access Publication Fund of the University of Tübingen.
References
- 1↑
Pekic S , Bogosavljevic V , Peker S , et al. Lymphocytic hypophysitis successfully treated with stereotactic radiosurgery: case report and review of the literature. J Neurol Surg Cent Eur Neurosurg 2018 79 77–85. (https://doi.org/10.1055/s-0037-1604079)
- 2↑
Langlois F , Varlamov EV & Fleseriu M . Hypophysitis, the growing spectrum of a rare pituitary disease. J Clin Endocrinol Metab 2022 107 10–28. (https://doi.org/10.1210/clinem/dgab672)
- 3↑
Donegan D & Honegger J . Hypophysitis. Endocr Pract 2022 28 901–910. (https://doi.org/10.1016/j.eprac.2022.06.009)
- 4↑
Ikeda J , Kuratsu J , Miura M , et al. Lymphocytic adenohypophysitis accompanying occlusion of bilateral internal carotid arteries–case report. Neurol Med Chir 1990 30 346–349. (https://doi.org/10.2176/nmc.30.346)
- 5↑
Gendreitzig P , Honegger J & Quinkler M . Granulomatous hypophysitis causing compression of the internal carotid arteries reversible with azathioprine and rituximab treatment. Pituitary 2020 23 103–112. (https://doi.org/10.1007/s11102-019-01005-2)
- 6↑
Kanoke A , Ogawa Y , Watanabe M , et al. Autoimmune hypophysitis presenting with intracranial multi-organ involvement: three case reports and review of the literature. BMC Res Notes 2013 6 560. (https://doi.org/10.1186/1756-0500-6-560)
- 7↑
Katsiveli P , Sfakiotaki M , Voulgaris N , et al. A complicated case of primary hypophysitis with bilateral intracavernous carotid artery occlusion. Hormones 2016 15 291–296. (https://doi.org/10.14310/horm.2002.1657)
- 8↑
Leung GK , Lopes MB , Thorner MO , et al. Primary hypophysitis: a single-center experience in 16 cases. J Neurosurg 2004 101 262–271. (https://doi.org/10.3171/jns.2004.101.2.0262)
- 9↑
Melgar MA , Mariwalla N , Gloss DS , et al. Recurrent lymphocytic hypophysitis and bilateral intracavernous carotid artery occlusion. an observation and review of the literature. Neurol Res 2006 28 177–183. (https://doi.org/10.1179/016164105X39996)
- 10↑
Peruzzotti-Jametti L , Strambo D , Sangalli F , et al. Bilateral intracavernous carotid artery occlusion caused by invasive lymphocytic hypophysitis. J Stroke Cerebrovasc Dis 2012 21 918 e9–e11. (https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.06.003)
- 11↑
Zoeller GK , Benveniste RJ , Farhadi FA , et al. Lymphocytic hypophysitis in a patient presenting with sequential episodes of optic neuritis. Pituitary 2012 15 101–105. (https://doi.org/10.1007/s11102-010-0244-5)
- 12↑
Supler ML & Mickle JP . Lymphocytic hypophysitis: report of a case in a man with cavernous sinus involvement. Surg Neurol 1992 37 472–476. (https://doi.org/10.1016/0090-3019(92)90138-d)
- 13↑
Nakata Y , Sato N , Masumoto T , et al. Parasellar T2 dark sign on MR imaging in patients with lymphocytic hypophysitis. AJNR Am J Neuroradiol 2010 31 1944–1950. (https://doi.org/10.3174/ajnr.A2201)
- 14↑
Lin M , Tsang V , Brewer J , et al. Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil. Endocrinol Diabetes Metab Case Rep 2020 2020 20–0041. (https://doi.org/10.1530/EDM-20-0041)
- 15↑
Watanabe Y , Maruoka H , Yokote H , et al. Recurrent lymphocytic hypophysitis presenting as internal carotid artery stenosis and oculomotor nerve palsy. Intern Med 2024 63 1623–1625. (https://doi.org/10.2169/internalmedicine.2674-23)
- 16↑
Rojas SGPN , Gomez MPP , Vargas S , et al. Occlusion of the cavernosal portion of the internal carotid artery, secondary to IgG4 hypophysitis. J Cancer Prev Curr Res 2022 13 56–59.
- 17↑
Waldie AM , Lau O , Gild M , et al. Lymphocytic hypophysitis presenting as bilateral abducens nerve palsy: a case report. Neuroophthalmology 2020 44 121–124. (https://doi.org/10.1080/01658107.2018.1561721)
- 18↑
Mori K , Takeuchi J , Ishikawa M , et al. Occlusive arteriopathy and brain tumor. J Neurosurg 1978 49 22–35. (https://doi.org/10.3171/jns.1978.49.1.0022)
- 19↑
Spallone A . Occlusion of the internal carotid artery by intracranial tumors. Surg Neurol 1981 15 51–57. (https://doi.org/10.1016/s0090-3019(81)80091-2)
- 20↑
Launay M , Fredy D , Merland JJ , et al. Narrowing and occlusion of arteries by intracranial tumors. Review of the literature and report of 25 cases. Neuroradiology 1977 14 117–126. (https://doi.org/10.1007/BF00333054)
- 21↑
Anaissie EJ & Shikhani AH . Rhinocerebral mucormycosis with internal carotid occlusion: report of two cases and review of the literature. Laryngoscope 1985 95 1107–1113. (https://doi.org/10.1288/00005537-198509000-00018)
- 22↑
Headings DL & Glasgow LA . Occlusion of the internal carotid artery complicating Haemophilus influenzae meningitis. Am J Dis Child 1977 131 854–856. (https://doi.org/10.1001/archpedi.1977.02120210032006)
- 23↑
Galetta SL , Wulc AE , Goldberg HI , et al. Rhinocerebral mucormycosis: management and survival after carotid occlusion. Ann Neurol 1990 28 103–107. (https://doi.org/10.1002/ana.410280121)
- 24↑
Molitch ME , Cowen L , Stadiem R , et al. Tumors invading the cavernous sinus that cause internal carotid artery compression are rarely pituitary adenomas. Pituitary 2012 15 598–600. (https://doi.org/10.1007/s11102-012-0375-y)
- 25↑
Buxton N & Robertson I . Lymphocytic and granulocytic hypophysitis: a single centre experience. Br J Neurosurg 2001 15 242–245. (https://doi.org/10.1080/02688690120057664)
- 26↑
Honegger J , Schlaffer S , Menzel C , et al. Diagnosis of primary hypophysitis in Germany. J Clin Endocrinol Metab 2015 100 3841–3849. (https://doi.org/10.1210/jc.2015-2152)
- 27↑
Donegan D , Saeed Z , Delivanis DA , et al. Outcomes of initial management strategies in patients with autoimmune lymphocytic hypophysitis: a systematic review and meta-analysis. J Clin Endocrinol Metab 2022 107 1170–1190. (https://doi.org/10.1210/clinem/dgab839)
- 28↑
Gutenberg A , Larsen J , Lupi I , et al. A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. AJNR Am J Neuroradiol 2009 30 1766–1772. (https://doi.org/10.3174/ajnr.A1714)
- 29↑
Honegger J , Buchfelder M , Schlaffer S , et al. Treatment of primary hypophysitis in Germany. J Clin Endocrinol Metab 2015 100 3460–3469. (https://doi.org/10.1210/jc.2015-2146)
- 30↑
Hacioglu A , Karaca Z , Uysal S , et al. Evaluation and follow-up of patients diagnosed with hypophysitis: a cohort study. Eur J Endocrinol 2024 191 312–322. (https://doi.org/10.1093/ejendo/lvae101)